Clinical Trial

Orthorexia Nervosa in Postmenopausal Osteoporosis

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 27, 2025 (before its estimated May 20, 2025 completion). Its status may not reflect the trial's current state.
Summary
A total of 64 female patients diagnosed with osteoporosis based on dual-energy X-ray absorptiometry (DXA) measurements performed within the last six months, and 64 age-matched healthy controls without osteoporosis, will be included in our study. Sociodemographic data such as age, sex, height, weight, and BMI will be recorded. Additionally, information regarding the duration of osteoporosis diagnosis, current treatments, history of fractures, history of falls, comorbidities, and smoking status will be collected. Femoral neck and L1-L4 T-scores and bone mineral density values obtained from existing DXA scans will be documented. Orthorexia nervosa-related symptoms will be assessed using the ORTO-11 scale, mood will be evaluated using the Hospital Anxiety and Depression Scale (HADS), and body image will be assessed using the Body Appreciation Scale-2.
Trial Details
NCT Number NCT06947213
Lead Sponsor Beylikduzu State Hospital
Conditions Osteoporosis
Enrollment 128 participants
Start Date 2025-04-20
Primary Completion 2025-05-20 (estimated)
Study Completion 2025-05-20 (estimated)
Updated on ClinicalTrials.gov 2025-04-27